This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Aucentra Therapeutics Pty Ltd, Aucentra Holdings Pty Ltd. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New South Wales, AU (2019)
- Marden, AU (2022)
- Artarmon, AU (2024)
Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Mingfeng Yu
Introduction
Mingfeng Yu is a notable inventor based in Marden, Australia. He has made significant contributions to the field of therapeutic agents, particularly in the development of compounds aimed at treating proliferative diseases, including various forms of cancer. With a total of 5 patents to his name, Yu's work exemplifies the intersection of innovation and medical science.
Latest Patents
Mingfeng Yu's latest patents include groundbreaking research on derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine. These compounds are designed as therapeutic agents capable of inhibiting cell proliferation by targeting the activity of FLT3 and its mutant forms, as well as other protein kinases such as CDKs. Another significant patent involves N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives, which serve as inhibitors of protein kinases. These inhibitors are particularly useful in treating diseases characterized by the over-expression of CDK4, CDK6, and cyclin D, including various cancers such as lung, breast, brain, central nervous system, colorectal cancer, and leukemias.
Career Highlights
Throughout his career, Mingfeng Yu has worked with several companies, including Aucentra Therapeutics Pty Ltd and Aucentra Holdings Pty Ltd. His innovative research has positioned him as a key figure in the development of new therapeutic strategies for cancer treatment.
Collaborations
Mingfeng Yu has collaborated with notable professionals in his field, including Shudong Wang and Solomon Tadesse Zeleke. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Mingfeng Yu's contributions to the field of therapeutic agents highlight his commitment to advancing medical science through innovation. His patents and collaborations reflect a dedication to improving treatment options for patients facing serious health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile